AcelRx Pharmaceuticals, Inc. (ACRX) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Order 2023 Financial Results Conference Call. This call is being webcast live via the events page. of the investor section of Excel's website. at www.accelerx.com. call the property XLRX. In any recording, reproduction, or transmission of this call without the express written consent of XLRS is strictly prohibited. As a reminder, today's webcast presentation is being recorded. You may listen to a replay of this webcast by going to the investor section of XLRX's website. I would now like to turn the call over to Rafi Asadorian, XLRX Chief Financial Officer. Please go ahead. Thank you for joining us on the call today. This afternoon, we announced our second quarter 2023 financial results and associated business updates in a press release. This press release can be found within the investors section of our website. With me today are Vince Angotti, our chief executive officer, and Dr. Pam Palmer, Accelerex's founder and chief medical officer. Before we begin, I want to remind listeners that during this call, we will likely make forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks and uncertainties regarding the operations and future results of Accelerex. Please refer to our press release in addition to the company's periodic, current, and annual reports filed with the Securities and Exchange Commission for a discussion of the risks associated with such forward-looking statements. These documents can also be found on our website at www.accelerex.com. I will now hand the call over to Vince. Thank you, Rafi, and good afternoon, everyone. We're excited to provide an update to you today on the progress related to our transformation, including the divestment of Desuvia and the advancement of our late-stage...